Grigor'ev A V, Bondarenko V M, Abramov N A, Murashova A O, Feklisova L V, Chuprinina R P
Zh Mikrobiol Epidemiol Immunobiol. 1997 May-Jun(3):92-6.
A new probiotic "Bifidumbacterin forte" containing bifidobacteria immobilized on carbon sorbent has been developed. The results of extensive clinical observation on the use of the preparation in patients (children and adults) with the infectious and surgical pathology of the gastrointestinal tract are presented. The clinico-bacteriological effect thus obtained makes it possible to recommend this new probiotic "Bifidumbacterin forte" for medical practice for the complex treatment of children and adults with acute and chronic diseases of the gastrointestinal tract.
一种新型益生菌“强力双歧杆菌素”已研制成功,它含有固定在碳吸附剂上的双歧杆菌。本文展示了该制剂在患有胃肠道感染性和外科疾病的患者(儿童和成人)中广泛临床观察的结果。由此获得的临床细菌学效果使得推荐这种新型益生菌“强力双歧杆菌素”用于医学实践中,对患有急慢性胃肠道疾病的儿童和成人进行综合治疗成为可能。